Combating multidrug-resistant Helicobacter pylori with moenomycin A in combination with clarithromycin or metronidazole

Current treatment of Helicobacter pylori involves a triple therapy comprising one proton pump inhibitor and two other antibiotics; however, the outcomes are limited due to the existence of antibiotic resistant strains. We previously reported that moenomycin A, a cell-wall transglycosylase inhibitor,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Yen-Yu, Liou, Jyh-Ming, Cheng, Wei-Chieh, Hsu, Jing-Ting, Hsu, Tsui-Ling, Wu, Ming-Shiang, Wong, Chi-Huey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627312/
https://www.ncbi.nlm.nih.gov/pubmed/36339034
http://dx.doi.org/10.3389/fchem.2022.897578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627312/
https://www.ncbi.nlm.nih.gov/pubmed/36339034
http://dx.doi.org/10.3389/fchem.2022.897578

Ejemplares similares